Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006-2020.

Julia LiawMeera HarhaySoko SetoguchiTobias GerhardChintan V Dave

Published in: Diabetes care (2022)

SGLT2i use increased among patients with T2DM, but this increase was largely driven by patients without CKD. Work is needed to identify barriers associated with the uptake of therapies with proven cardiorenal benefits (e.g., SGLT2i, GLP-1RA) among patients with CKD.

Keyphrases

chronic kidney disease
end stage renal disease
peritoneal dialysis
primary care
ejection fraction
prognostic factors
metabolic syndrome
skeletal muscle
decision making
insulin resistance
systemic sclerosis
ankylosing spondylitis
systemic lupus erythematosus